Gilder, Gagnon, Howe & Co »

Alnylam Pharmaceuticals shares owned by Gilder, Gagnon, Howe & Co

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Gilder, Gagnon, Howe & Co from 13F filings

Historical chart of Gilder, Gagnon, Howe & Co investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Gilder, Gagnon, Howe & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Gilder, Gagnon, Howe & Co

Quarter filed Position value Share count Share price at filing
2013-03-31 $27M 1.1M 24.37

More positions owned by Gilder, Gagnon, Howe & Co

NVIDIA Corporation (NVDA)
Amazon (AMZN)
Tesla Motors (TSLA)
Netflix (NFLX)
Meta Platforms Cl A (META)
Intuitive Surgical Com New (ISRG)
Duolingo Cl A Com (DUOL)
Freshpet (FRPT)
Eli Lilly & Co. (LLY)
Cloudflare Cl A Com (NET)
Natera (NTRA)
Shake Shack Cl A (SHAK)
Quanta Services (PWR)
Arista Networks (ANET)
Appfolio Com Cl A (APPF)

View all positions for Gilder, Gagnon, Howe & Co

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
FMR
Vanguard Group
BlackRock
Capital Research Global Investors
Wellington Management Company
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies

View all funds holding Alnylam Pharmaceuticals